Site-110 — Canton, Ohio

Site-110 is a clinical research site located in Canton, Ohio, United States 44718.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site-110 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Graves Disease.

Sponsors: Biohaven Therapeutics Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Canton

Browse all research sites in Ohio · View every site in Canton

• Aultman Hospital; Aultman Hospital Cancer Center
• Piedmont Hospital, Inc.
• Aultman Hospital Cancer Center at Aultman Health Foundation
• Cleveland Clinic Mercy Hospital
• Aultman Hospital Research
• Aultman Hospital, Cardiovascular Consultants, Inc
• Aultman Hospital Clinical Trials
• Mercy Hospital
• Cleveland Clinic Mercy Hospital Cancer Center
• Medical Oncology Aultman Hospital
• University Hospitals Ireland Cancer Center at Mercy Medical Center
• Aultman Hospital Cancer Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site-110?

Site-110 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site-110 conducted?

Site-110 has 1 clinical trials on record, with 1 currently active. Their work covers Graves Disease.

Is Site-110 accredited by Crixeo Clinical Trials?

Site-110 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site-110?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.